Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

May 09, 2018

An emergency team with the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is working with the Ministry of Health in the Democratic Republic of Congo and other international organizations to assess and support a rapid response to an Ebola outbreak in the country, confirmed by national health authorities on May 8.

January 31, 2018

Doctors Without Borders/Médecins Sans Frontières (MSF) opened a pediatric surgical program at Bardnesville Junction Hospital (BJH) on the outskirts of Liberia's capital Monrovia on Jan. 11, with a goal of making surgical care more available for children in the country.

September 14, 2016

New report exposes pharmaceutical industry failings and highlights new ways of researching and developing medicines that address public health needs.

January 07, 2016

Doctors Without Borders retrospective study finds lower mortality risk among patients given a particular malaria medicine.

May 09, 2015

MONROVIA, LIBERIA/BRUSSELS—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the World Health Organization's declaration that Liberia is Ebola-free after 42 days with no recorded cases, while warning that the outbreak is not over, as new cases continue in neighboring Guinea and Sierra Leone.

Cross-border surveillance must be improved to prevent Ebola from re-emerging in Liberia, MSF said.

March 20, 2015

MSF releases a critical analysis of the global Ebola response one year into the deadliest outbreak in history.

February 24, 2015

Initial results of a clinical trial of the experimental drug favipiravir suggest that it can reduce mortality among patients with low levels of the Ebola virus in their blood, but is ineffective for patients with high viral loads who are very sick with the disease.

February 04, 2015

BRUSSELS/NEW YORKA trial of the experimental Ebola drug brincidofovir in Liberia has officially ended due to a significant drop in the number of new Ebola cases and the drug manufacturer’s decision to withdraw from the trial, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières said Tuesday. 

December 10, 2014

1.5 million people in Freetown and surrounding area to receive medicines.

Pages